IGF2 and prostate carcinoma: Indeed, it has been surprisingly demonstrated that high levels of 25(OH)D, in presence of insulin like growth factor 2 (IGF2), may increase prostate cancer risk (OR:1.33; 95% CI: 1.00 to 1.65; p = 0.04) [103].